Brief: Hansoh Pharmaceutical Discloses Transactions With Avere Therapeutics
14/07/2026 16:26
BRIEF-Hansoh Pharmaceutical Discloses Transactions With Avere Therapeutics July 14 (Reuters) - Hansoh Pharmaceutical Group Company Ltd 3692.HK:
TRANSACTIONS WITH AVERE THERAPEUTICS
COMBINED ENTITY TO OPERATE AS AVERE THERAPEUTICS, AND TRADE AS AVRX
HANSHOH PHARMA TO HOLD OVER 30% BUT UNDER 40% OF COMBINED ENTITY POST-MERGER
Further company coverage: 3692.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hansoh Pharmaceutical
See all newsHansoh Pharmaceutical jumps most in 8 weeks on Roche tie-up
Deals of the day-Mergers and acquisitions
Factbox: Major drugmakers turn to China for licensing deals
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion (updated)
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion